J.K. Mellon

923 total citations
20 papers, 731 citations indexed

About

J.K. Mellon is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, J.K. Mellon has authored 20 papers receiving a total of 731 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in J.K. Mellon's work include Bladder and Urothelial Cancer Treatments (5 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). J.K. Mellon is often cited by papers focused on Bladder and Urothelial Cancer Treatments (5 papers), Peptidase Inhibition and Analysis (3 papers) and Protease and Inhibitor Mechanisms (3 papers). J.K. Mellon collaborates with scholars based in United Kingdom, Australia and Denmark. J.K. Mellon's co-authors include T.R. Leyshon Griffiths, John Lunec, J E Nutt, Ricky A. Sharma, P. Rajjayabun, Eugene Tulchinsky, Marina Kriajevska, W.P. Steward, A. Gescher and Mary Robinson and has published in prestigious journals such as Oncogene, The Journal of Urology and British Journal of Cancer.

In The Last Decade

J.K. Mellon

20 papers receiving 715 citations

Peers

Countries citing papers authored by J.K. Mellon

Since Specialization

Citations

This map shows the geographic impact of J.K. Mellon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.K. Mellon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.K. Mellon more than expected).

Fields of papers citing papers by J.K. Mellon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.K. Mellon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.K. Mellon. The network helps show where J.K. Mellon may publish in the future.

Co-authorship network of co-authors of J.K. Mellon

This figure shows the co-authorship network connecting the top 25 collaborators of J.K. Mellon. A scholar is included among the top collaborators of J.K. Mellon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.K. Mellon. J.K. Mellon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Anaphylactic reaction to intraurethral chlorhexidine: sensitisation following previous repeated uneventful administration 2013 ·Annals of The Royal College of Surgeons of England ·(unknown), (unknown), J.K. Mellon, (unknown)	10
2	Fra-1 controls motility of bladder cancer cells via transcriptional upregulation of the receptor tyrosine kinase AXL 2011 ·Oncogene ·Emre Sayan, (unknown), Robert K. Vickery, Elena Grigorenko, Jeannine Diesch, (unknown), Richard Edwards, Rekha Pal, Peter Greaves, Isabelle Jariel‐Encontre, Marc Piechaczyk, Marina Kriajevska, J.K. Mellon, Amardeep S. Dhillon, Eugene Tulchinsky	86
3	Urethral Venous Malformation: An Unusual Cause of Recurrent Post-Coital Gross Haematuria in Association with Haematospermia 2009 ·Annals of The Royal College of Surgeons of England ·(unknown), Masood A. Khan, (unknown), J.K. Mellon	4
4	THE FUNCTION OF ZEB1 IN BLADDER CANCER 2008 ·European Urology Supplements ·(unknown), (unknown), J.K. Mellon, Eugene Tulchinsky, Marina Kriajevska, T.R. Leyshon Griffiths	1
5	Metastasis-Associated Protein S100A4: Spotlight on its Role in Cell Migration 2007 ·Current Cancer Drug Targets ·Svetlana Tarabykina, T.R. Leyshon Griffiths, Eugene Tulchinsky, J.K. Mellon, Igor Bronstein, Marina Kriajevska	91
6	A Review of Phase III Clinical Trials of Prostate Cancer Chemoprevention 2007 ·Annals of The Royal College of Surgeons of England ·(unknown), Sunjay Jain, (unknown), A. Gescher, W.P. Steward, J.K. Mellon	18
7	Oxidative stress and cyclooxygenase activity in prostate carcinogenesis: targets for chemopreventive strategies 2004 ·European Journal of Cancer ·(unknown), Ricky A. Sharma, W.P. Steward, J.K. Mellon, T.R. Leyshon Griffiths, A. Gescher	103
8	Concomitant chemoradiotherapy for muscle-invasive bladder cancer: the way forward for bladder preservation? 2004 ·Clinical Oncology ·(unknown), George D.D. Jones, J.K. Mellon, Roger Kockelbergh, William P. Steward, R.P. Symonds	9
9	Chemoprevention of prostate cancer comes of age 2004 ·British Journal of Urology ·J.K. Mellon	2
10	THE ROLE OF SPECIAL CUTTING EQUIPMENT AND CORPOREAL ASPIRATION IN THE TREATMENT OF PENILE INCARCERATION WITH A BARBELL RETAINING COLLAR 2004 ·The Journal of Urology ·(unknown), J.K. Mellon	14
11	Testicular prostheses: a new technique for insertion 2003 ·British Journal of Urology ·Matthew Simms, S. S. Huq, J.K. Mellon	7
12	Matrix metalloproteinases (MMPs) in bladder cancer: the induction of MMP9 by epidermal growth factor and its detection in urine 2003 ·British Journal of Urology ·J E Nutt, (unknown), J.K. Mellon, John Lunec	69
13	Chemoprevention of prostate cancer by diet-derived antioxidant agents and hormonal manipulation (Review) 2003 ·International Journal of Oncology ·(unknown), Ricky A. Sharma, J.K. Mellon	35
14	Improving the utility of prostate specific antigen (PSA) in the diagnosis of prostate cancer: the use of PSA derivatives and novel markers 2002 ·Postgraduate Medical Journal ·(unknown), (unknown), J.K. Mellon	24
15	Caveolin-1 expression is associated with high-grade bladder cancer 2001 ·Urology ·P. Rajjayabun, (unknown), (unknown), Richard Charlton, Mary Robinson, J.K. Mellon	98
16	Prognostic significance of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in voided urine samples from patients with transitional cell carcinoma of the bladder. 2001 ·PubMed ·(unknown), J E Nutt, P. Rajjayabun, David E. Neal, John Lunec, J.K. Mellon	37
17	Matrix metalloproteinase-1 is induced by epidermal growth factor in human bladder tumour cell lines and is detectable in urine of patients with bladder tumours 1998 ·British Journal of Cancer ·J E Nutt, J.K. Mellon, Khaver Qureshi, John Lunec	36
18	Cell adhesion molecules in bladder cancer: soluble serum E-cadherin correlates with predictors of recurrence 1996 ·British Journal of Cancer ·T.R. Leyshon Griffiths, I. Brotherick, (unknown), (unknown), (unknown), C. H. W. Horne, B.K. Shenton, David E. Neal, J.K. Mellon	78
19	P53 and ploidy assessed by flow cytometry in bladder washings 1995 ·British Journal of Urology ·T.R. Leyshon Griffiths, J.K. Mellon, (unknown), B.K. Shenton, David E. Neal	6
20	Oesophago-pericardial fistula and cardiac tamponade after oesophagoscopy 1988 ·European Journal of Cardio-Thoracic Surgery ·J.K. Mellon, Ivor F. Galvin, (unknown), J J Gibbons, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact